MedTrace Logo

Effect of Vitamin D Supplementation on Inflammatory Markers

NCT03782805 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2018-12-21

No results posted yet for this study

Summary

Previous studies have shown that improving vitamin D status among the elderly may lead to an improvement in some inflammatory markers, especially with patients with type 2 diabetes. The aim of our trial is study the effect of vitamin D supplementation on inflammatory markers in patients having type 2 diabetes.

Conditions

  • Vitamin D Deficiency
  • Type2 Diabetes

Interventions

DIETARY_SUPPLEMENT

cholecalciferol (Euro-Pharm International, Canada)

The participants are randomly asked to take either a pill containing either a supplement of cholecalciferol or placebo for 3 times a week, within a period of 6 months

DIETARY_SUPPLEMENT

Placebo tablet

The participants are randomly asked to take either a pill containing either a supplement of cholecalciferol or placebo for 3 times a week, within a period of 6 months

Sponsors & Collaborators

  • Université d'Auvergne

    lead OTHER

Principal Investigators

  • Cynthia E Hajj, PhD · Dr

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
72 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-09
Primary Completion
2018-06-07
Completion
2018-07-09

Countries

  • Lebanon

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03782805 on ClinicalTrials.gov